What We Do
Q Fever: Our Response
Although it is rarely severe from the outset, Q fever is present worldwide, with the exception of New Zealand, and can, in about 1% of cases, become chronic with serious cardiovascular complications: endocarditis, aneurysmal infections.
The main public health concern regarding Q fever in France is its potential for epidemics in humans. In this context, Santé publique France and the National Reference Center for Rickettsia, Coxiella, and Bartonella conduct epidemiological surveillance of Q fever to track trends and detect unusual events and clusters of cases.
Epidemiological surveillance of Q fever
Epidemiological surveillance of Q fever is conducted by Santé publique France in collaboration with the National Reference Center for Rickettsia, Bartonella, and Coxiella, based on diagnoses confirmed by the NRC and reports of suspected clusters of cases from healthcare professionals.
See also
Surveillance of Q fever in animals
Surveillance Partners
The National Reference Center (CNR)
Director: Prof. Pierre-Edouard FOURNIER
Email: pierre-edouard.fournier@univ-amu.fr
Address: Aix-Marseille University
IHU Méditerranée-Infection
19-21, boulevard Jean Moulin - 13385 Marseille Cedex 05
Office: 04 13 73 24 01 - Fax: 04 13 73 24 02 CNR Coxiella and
Bartonella Rickettsiae website:
https://www.mediterranee-infection.com/diagnostic/les-centres-nationaux-de-reference-cnr/cnr-rickettsioses/
Directorate General for Food (DGAL)
10 Rue du Séminaire, 94550 Chevilly-Larue
ANSES (LNR Coxiella):
14 Rue Pierre et Marie Curie, 94700 Maisons-Alfort
